Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Med Intensiva (Engl Ed) ; 43(6): 329-336, 2019.
Article in English, Spanish | MEDLINE | ID: mdl-29910113

ABSTRACT

OBJECTIVE: To determine the predictive value of the inotropic score (IS) and vasoactive-inotropic score (VIS) in low cardiac output syndrome (LCOS) in children after congenital heart disease surgery involving cardiopulmonary bypass (CPB), and to establish whether mid-regional pro-adrenomedullin (MR-proADM) and cardiac troponin I (cTn-I), associated to the IS and VIS scores, increases the predictive capacity in LCOS. DESIGN: A prospective observational study was carried out. SETTING: A Paediatric Intensive Care Unit. PATIENTS: A total of 117children with congenital heart disease underwent CPB. Patients were divided into two groups: LCOS and non-LCOS. INTERVENTIONS: The clinical and analytical data were recorded at 2, 12, 24 and 48h post-CPB. Logistic regression was used to develop a risk prediction model using LCOS as dependent variable. MAIN OUTCOME MEASURES: LCOS, IS, VIS, MR-proADM, cTn-I, age, sex, CPB time, PIM-2, Aristotle score. RESULTS: While statistical significance was not recorded for IS in the multivariate analysis, VIS was seen to be independently associated to LCOS. On the other hand, VIS>15.5 at 2h post-CPB, adjusted for age and CPB timepoints, showed high specificity (92.87%; 95%CI: 86.75-98.96) and increased negative predictive value (75.59%, 95%CI: 71.1-88.08) for the diagnosis of LCOS at 48h post-CPB. The predictive power for LCOS did not increase when VIS was combined with cTn-I >14ng/ml at 2h and MR-proADM >1.5nmol/l at 24h post-CPB. CONCLUSIONS: The VIS score at 2h post-CPB was identified as an independent early predictor of LCOS. This predictive value was not increased when associated with LCOS cardiac biomarkers. The VIS score was more useful than IS post-CPB in making early therapeutic decisions in clinical practice post-CPB.


Subject(s)
Adrenomedullin/blood , Cardiac Output, Low/blood , Cardiopulmonary Bypass , Heart Defects, Congenital/blood , Heart Defects, Congenital/surgery , Peptide Fragments/blood , Postoperative Complications/blood , Protein Precursors/blood , Troponin I/blood , Adolescent , Cardiotonic Agents/therapeutic use , Cardiovascular Agents/therapeutic use , Child , Child, Preschool , Female , Humans , Infant , Male , Predictive Value of Tests , Prospective Studies
3.
An Esp Pediatr ; 57(5): 480-3, 2002 Nov.
Article in Spanish | MEDLINE | ID: mdl-12467552

ABSTRACT

Ventricular assist devices have demonstrated their utility in patients with intractable cardiac failure, both as support until complete myocardial recovery and as a bridge to transplantation. Specific pediatric pneumatic paracorporeal systems can be applied even in infants. Long-term survival has been reported although experience is limited. We report the case of an 8-year-old boy with dilated cardiomyopathy awaiting cardiac transplantation. The patient developed profound cardiogenic shock with multiorgan failure while being evaluated for heart transplantation. He was given biventricular assistance with the MEDOS-HIA system (MEDOS-Helmholtz Institute). Maximum stroke volume ventricles of 25 and 22 ml were used, achieving a cardiac output of 2.2 l/min in both ventricles. The patient was supported with ventricular assistance for 9 days, but multiple organ failed to improve and transplantation became impossible. Progressive loss of peripheral circulatory resistance unresponsive to treatment developed and ventricular assistance was discontinued. The previous severe shock and advanced and progressive multiorgan failure could be responsible for the poor outcome of our patient despite maintenance of adequate cardiac output. Nevertheless, the use of ventricular assist devices is a real therapeutic alternative in children with severe cardiogenic shock, allowing them to recover completely or undergo heart transplantation. Patient selection, the choice of a system of appropriate size, and early implantation seem to be the cornerstones for obtaining good results.


Subject(s)
Cardiomyopathy, Dilated/therapy , Heart-Assist Devices , Cardiomyopathy, Dilated/complications , Child , Heart Transplantation , Humans , Male , Multiple Organ Failure/etiology , Shock, Cardiogenic/etiology , Waiting Lists
4.
Arch Inst Cardiol Mex ; 69(3): 235-40, 1999.
Article in Spanish | MEDLINE | ID: mdl-10529857

ABSTRACT

Deep venus thrombosis may result in pulmonary embolism. In rare instances, embolization has occurred, not directly to the pulmonary arterial tree, but to the right heart chambers. Although the value of echocardiography in the diagnosis is well recognised, their is no consensus for the appropriate treatment. We report herein six cases of floating right atrial thrombi, diagnosed by echocardiography, in patients with pulmonary embolism, or unexplained shock or syncope. Surgical embolectomy was carried out in 4 patients, and thrombolytic therapy in 2, without in-hospital mortality. The high mortality associated to this entity may be improved by rapid echocardiographic recognition and emergency treatment with thrombolysis or surgery. Our data suggest the possible use of thrombolysis as a first-choice therapy in selected patients.


Subject(s)
Embolism/diagnosis , Heart Diseases/diagnosis , Adult , Aged , Drug Therapy, Combination , Echocardiography , Embolectomy/methods , Embolism/therapy , Female , Fibrinolytic Agents/administration & dosage , Heart Diseases/therapy , Heparin/administration & dosage , Humans , Lung/diagnostic imaging , Male , Radionuclide Imaging , Streptokinase/administration & dosage , Thrombolytic Therapy , Ventilation-Perfusion Ratio
SELECTION OF CITATIONS
SEARCH DETAIL